The NaviStar ThermoCool Catheter is available for the treatment of adults with specific rapid heartbeats who have already experienced failure with other treatments, such as device or other antiarrhythmic drug therapy. These specific rapid heartbeats are scientifically known as ventricular tachycardia (VT) that arise following a heart attack. The catheter is the first FDA-approved catheter to treat both mappable and unmappable VTs. The expanded indication provides cardiac electrophysiologists with a new treatment option for the estimated three million people in the U.S.

Developed to help hospitals seamlessly bring their entire portfolio of wireless services and applications together on a single infrastructure, Enterprise Access with Wireless Medical Telemetry Service (WMTS) enables healthcare organizations to harness the power of next-generation wireless computing throughout their facilities.

HeartCentrix is a software solution that enables Burdick and Quinton stress, Holter and ECG devices to communicate seamlessly with physician office-based electronic medical record (EMR) systems. Cardiac Science owns the Burdick and Quinton brands.

The first third-generation drug-eluting stent is now available to physicians and patients in many markets around the world, including countries in Western and Eastern Europe, Asia Pacific and the Middle East. Cordis Corp. expects to offer the CYPHER SELECT Plus Stent in most markets outside the U.S. and Japan within the next two quarters.

The AngioJet SpiroflexVG Rheolytic Thrombectomy catheter is the first AngioJet catheter of its size to be offered in a Rapid Exchange platform.
Utilizing its proprietary Spiroflex shaft technology, the Spiroflex VG catheter benefits from several design improvements made to the most recent generation of Possis Medical products. The catheter offers improved trackability inside the vessel and includes tip and hub improvements found on the recently introduced Spiroflex catheter. The Spiroflex VG Catheter is fully released for sale in the U.S. for peripheral use.

With several integrated cardiac features, CARESTREAM PACS includes cardiac review and analysis, cardiac cage removal in 3-D imaging and cardiac calcium scoring.

The Emboshield PRO Embolic Protection System received CE approval and will be launched in Europe.
Embolic protection devices are designed to capture and remove particles of atherosclerotic plaque that can become dislodged during a carotid artery stenting procedure, potentially leading to stroke and other complications.

ZAC is a computer-aided heart sound analysis system that acquires, records and analyzes the acoustic signals of the heart and delivers the results in an easy-to-interpret graphical display. It also supports physicians in analyzing their patients’ heart sounds for suspected murmurs.

The next-generation FilmStation dry film imager dual-tray UP-DF550 model dramatically reduces dry imaging space requirements. The imager’s second tray offers 8-by-10-inch, 10-by-12-inch and 11-by-14-inch film sizes, in addition to its traditional film size of 14-by-17 inches.
Its unique configuration allows both vertical and horizontal positioning to accommodate a variety of site needs. If desired, FilmStation can stand upright directly under a desktop alongside a CPU.

A new platform architecture for TeraRecon’s Aquarius suite of products, iNtuition is designed to deliver integration of advanced imaging workflow into the healthcare enterprise and features an improved and more powerful central rendering resource in the form of the VolumePro 2000, based on the company’s FALCON chipset.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now